C L Crespi|D M Stresser - JoVE Visualize

Showing results (61-70 of 93) with videos related to

Pageof 10

Sort By:

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000

Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approachesK Venkatakrishnan, L L von Moltke, M H Court, et al.

Mutation Research|December 29, 1999

Mutagenicity of C24H14 PAH in human cells expressing CYP1A1J L Durant, A L Lafleur, W F Busby, et al.

Toxicology and Applied Pharmacology|January 13, 2000

Differential protection by rat UDP-glucuronosyltransferase 1A7 against Benzo[a]pyrene-3,6-quinone- versus Benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cellsA D Grove, G C Llewellyn, F K Kessler, et al.

Mutation Research|July 1, 1994

N-nitrosodiethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced morphological transformation of C3H/10T1/2CL8 cells expressing human cytochrome P450 2A6S Nesnow, S Beck, S Rosenblum, et al.

Pharmaceutical Research|September 25, 1999

Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductaseM Hu, Y Li, C M Davitt, et al.

Pharmacogenetics|February 1, 1993

Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6B W Penman, J Reece, T Smith, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1997

Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus systemL Chen, J T Buters, J P Hardwick, et al.

Pharmacogenetics|January 26, 1999

Detection and characterization of novel polymorphisms in the CYP2E1 geneK S Fairbrother, J Grove, I de Waziers, et al.

Chemical Research in Toxicology|September 1, 1991

A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testingC L Crespi, F J Gonzalez, D T Steimel, et al.

Clinical Pharmacology and Therapeutics|February 11, 2000

CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activityF Sata, A Sapone, G Elizondo, et al.

Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:

Pageof 10

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000

Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approachesK Venkatakrishnan, L L von Moltke, M H Court, et al.

Mutation Research|December 29, 1999

Mutagenicity of C24H14 PAH in human cells expressing CYP1A1J L Durant, A L Lafleur, W F Busby, et al.

Toxicology and Applied Pharmacology|January 13, 2000

Differential protection by rat UDP-glucuronosyltransferase 1A7 against Benzo[a]pyrene-3,6-quinone- versus Benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cellsA D Grove, G C Llewellyn, F K Kessler, et al.

Mutation Research|July 1, 1994

N-nitrosodiethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced morphological transformation of C3H/10T1/2CL8 cells expressing human cytochrome P450 2A6S Nesnow, S Beck, S Rosenblum, et al.

Pharmaceutical Research|September 25, 1999

Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductaseM Hu, Y Li, C M Davitt, et al.

Pharmacogenetics|February 1, 1993

Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6B W Penman, J Reece, T Smith, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1997

Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus systemL Chen, J T Buters, J P Hardwick, et al.

Pharmacogenetics|January 26, 1999

Detection and characterization of novel polymorphisms in the CYP2E1 geneK S Fairbrother, J Grove, I de Waziers, et al.

Chemical Research in Toxicology|September 1, 1991

A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testingC L Crespi, F J Gonzalez, D T Steimel, et al.

Clinical Pharmacology and Therapeutics|February 11, 2000

CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activityF Sata, A Sapone, G Elizondo, et al.

Pageof 10